Form 8-K - Current report:
SEC Accession No. 0001140361-26-007249
Filing Date
2026-03-02
Accepted
2026-03-02 09:24:10
Documents
61
Period of Report
2026-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20066398_8k.htm   iXBRL 8-K 73569
2 EXHIBIT 2.1 ef20066398_ex2-1.htm EX-2.1 537021
3 EXHIBIT 3.1 ef20066398_ex3-1.htm EX-3.1 96788
4 EXHIBIT 10.1 ef20066398_ex10-1.htm EX-10.1 59443
5 EXHIBIT 10.2 ef20066398_ex10-2.htm EX-10.2 55286
6 EXHIBIT 10.3 ef20066398_ex10-3.htm EX-10.3 156793
7 EXHIBIT 10.4 ef20066398_ex10-4.htm EX-10.4 33770
8 EXHIBIT 99.1 ef20066398_ex99-1.htm EX-99.1 23161
9 EXHIBIT 99.2 ex20066398_ex99-2.htm EX-99.2 78204
13 image00001.jpg GRAPHIC 3783
14 image00002.jpg GRAPHIC 3290
15 image00023.jpg GRAPHIC 67584
16 image00024.jpg GRAPHIC 311148
17 image00025.jpg GRAPHIC 101938
18 image00026.jpg GRAPHIC 82582
19 image00027.jpg GRAPHIC 115711
20 image00028.jpg GRAPHIC 91557
21 image00029.jpg GRAPHIC 95857
22 image00030.jpg GRAPHIC 44164
23 image00032.jpg GRAPHIC 116818
24 image00033.jpg GRAPHIC 45544
25 image00034.jpg GRAPHIC 93683
26 image00035.jpg GRAPHIC 108136
27 image00036.jpg GRAPHIC 88577
28 image00037.jpg GRAPHIC 139187
29 image00038.jpg GRAPHIC 134512
30 image00039.jpg GRAPHIC 46413
31 image00041.jpg GRAPHIC 118016
32 image00042.jpg GRAPHIC 124826
33 image00043.jpg GRAPHIC 123736
34 image00044.jpg GRAPHIC 106366
35 image00045.jpg GRAPHIC 38793
36 image00046.jpg GRAPHIC 96291
37 image00047.jpg GRAPHIC 124571
38 image00048.jpg GRAPHIC 91830
39 image00049.jpg GRAPHIC 150981
40 image00050.jpg GRAPHIC 125726
41 image00051.jpg GRAPHIC 112383
42 image00052.jpg GRAPHIC 44676
43 image00053.jpg GRAPHIC 102902
44 image00054.jpg GRAPHIC 93844
45 image00055.jpg GRAPHIC 129707
46 image00056.jpg GRAPHIC 89855
47 image00057.jpg GRAPHIC 91863
48 image00058.jpg GRAPHIC 100189
49 image00059.jpg GRAPHIC 111347
50 image00060.jpg GRAPHIC 107983
51 image00061.jpg GRAPHIC 43655
52 image9929.jpg GRAPHIC 87807
53 image99218.jpg GRAPHIC 108406
  Complete submission text file 0001140361-26-007249.txt   7046292

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA gyre-20260302.xsd EX-101.SCH 3907
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gyre-20260302_lab.xml EX-101.LAB 22691
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gyre-20260302_pre.xml EX-101.PRE 16580
64 EXTRACTED XBRL INSTANCE DOCUMENT ef20066398_8k_htm.xml XML 4366
Mailing Address 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130 (858) 567-7770
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 26703894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)